PMID 25869809)Tier 1 primary [4]Eric Topol, Ground Truths: The Peptide Craze (July 2025) - ipamorelin flagged for cancer risk on IGF-1 groundsTier 2 expert [5]FDA Pharmacy Compounding Advisory Committee meeting, 29 October 2024 (reviewed ipamorelin 503A eligibility)Tier 1 primary No revisions yet
In late July the FDAs Pharmacy Compounding Advisory Committee will spend two days deciding whether a handful of peptides should move one step closer to legal compounding
Unlike exogenous growth hormone, sermorelin preserves the pulsatile pattern of GH release that your body relies on for optimal fat metabolism
Challenges persist, however, such as stringent regulatory requirements across different regions, ingredient cost volatility (especially for high-quality glutathione), and the need for clear substantiation of efficacy claims
Focus protein intake on b12-rich sources rather than plant-based proteins during active weight loss